Atıf İçin Kopyala
TOYGAR DENİZ M., AKHAN S., SAYAN M., Tamer G. S., AZAK KARALİ E.
VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, cilt.28, sa.1, ss.25-31, 2022 (ESCI)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
28
Sayı:
1
-
Basım Tarihi:
2022
-
Doi Numarası:
10.4274/vhd.galenos.2022.2021-3-2
-
Dergi Adı:
VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
-
Derginin Tarandığı İndeksler:
Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
-
Sayfa Sayıları:
ss.25-31
-
Anahtar Kelimeler:
Hepatitis C virus, correlation, viral load, hepatitis C antibodies, CLINICAL UTILITY, ENZYME-IMMUNOASSAY, ASSAY, QUANTIFICATION, EPIDEMIOLOGY, PERFORMANCE, INFECTION, BURDEN, RNA
-
Kocaeli Üniversitesi Adresli:
Evet
Özet
Objectives: Recently, with the use of direct-acting antivirals (DAA) for treating chronic hepatitis C (CHC), the success rate has exceeded 90%. The implementation of these strong therapies has reduced the role of monitoring therapy with hepatitis C virus (HCV)-RNA tests. The current study compares the HCV-core antigen test (HCV-Ag) with HCV-RNA in terms of correlation, effectiveness and cost in patients who started DAA and to evaluate the usability of HCV-Ag as a routine laboratory test.